CCK in anxiety and cognitive processes

被引:113
作者
Daugé, V [1 ]
Léna, I [1 ]
机构
[1] Univ Paris 05, CNRS,UFR Sci Pharmaceut & Biol, URA D1500,INSERM,U266, Dept Pharmacochim Mol & Struct, F-75270 Paris 06, France
关键词
cholecystokinin; CCK-B receptor binding sites; CCK-B1; CCK-B2; stress; anxiety and panic; dopamine; attention and memory; nucleus accumbens;
D O I
10.1016/S0149-7634(98)00011-6
中图分类号
B84 [心理学]; C [社会科学总论]; Q98 [人类学];
学科分类号
03 ; 0303 ; 030303 ; 04 ; 0402 ;
摘要
Extensive studies were carried out on the involvement of the CCKergic system in anxiety-, panic- and stress-related behaviour. The stimulation of CCK-A or CCK-B receptors is implicated in the physical and psychological responses of CCK to stress. Furthermore, several selective CCK-B agonists produce anxiogenic-like effects, while CCK-B antagonists induce anxiolytic-like responses in several models of anxiety. However, BC264 a highly selective CCK-B agonist, does not produce anxiogenic-like effects but increases attention and/or memory. These effects are dependent on the dopaminergic systems. Together with biochemical data, this led to the hypothesis of the existence of two CCK-B binding sites, CCK-B1 and CCK-B2, which could correspond to different activation states of a single molecular entity. Investigations into CCK-B I and CCK-B2 systems might be of critical interest, since only one site, CCK-B1, appears to be responsible for the effects on anxiety. Furthermore, the improvement of attention and/or memory processes by CCK, through CCK-B2 receptors, could offer a new perspective in the treatment of attention and/or memory disorders. (C) 1998 Elsevier Science Ltd. All rights reserved.
引用
收藏
页码:815 / 825
页数:11
相关论文
共 145 条
  • [1] STIMULATION OF CORTICOTROPIN RELEASE BY PENTAGASTRIN IN NORMAL SUBJECTS AND PATIENTS WITH PANIC DISORDER
    ABELSON, JL
    NESSE, RM
    VINIK, A
    [J]. BIOLOGICAL PSYCHIATRY, 1991, 29 (12) : 1220 - 1223
  • [2] ABELSON JL, 1990, ARCH GEN PSYCHIAT, V47, P395
  • [3] A DOUBLE-BLIND, PLACEBO-CONTROLLED STUDY OF A CCK-B RECEPTOR ANTAGONIST, CI-988, IN PATIENTS WITH GENERALIZED ANXIETY DISORDER
    ADAMS, JB
    PYKE, RE
    COSTA, J
    CUTLER, NR
    SCHWEIZER, E
    WILCOX, CS
    WISSELINK, PG
    GREINER, M
    PIERCE, MW
    PANDE, AC
    [J]. JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY, 1995, 15 (06) : 428 - 434
  • [4] Akiyoshi J, 1996, J NEUROCHEM, V66, P1610
  • [5] EFFECTS OF SCOPOLAMINE, D-AMPHETAMINE AND OTHER DRUGS AFFECTING CATECHOLAMINES ON SPONTANEOUS ALTERNATION AND LOCOMOTOR ACTIVITY IN MICE
    ANISMAN, H
    KOKKINIDIS, L
    [J]. PSYCHOPHARMACOLOGIA, 1975, 45 (01): : 55 - 63
  • [6] [Anonymous], CHOLECYSTOKININ ANXI
  • [7] ANTIDEPRESSANT-TYPE EFFECTS OF ENDOGENOUS ENKEPHALINS PROTECTED BY SYSTEMIC RB-101 ARE MEDIATED BY OPIOID-DELTA AND DOPAMINE-D1 RECEPTOR STIMULATION
    BAAMONDE, A
    DAUGE, V
    RUIZGAYO, M
    FULGA, IG
    TURCAUD, S
    FOURNIEZALUSKI, MC
    ROQUES, BP
    [J]. EUROPEAN JOURNAL OF PHARMACOLOGY, 1992, 216 (02) : 157 - 166
  • [8] EFFECT OF CERULETIDE ON PITUITARY-HYPOTHALAMIC PEPTIDES AND ON EMOTION IN MAN
    BASSO, N
    MATERIA, A
    DINTINOSANTE, V
    GINALDI, A
    PONA, V
    REILLY, P
    RUGGERI, S
    FIORAVANTI, M
    [J]. PEPTIDES, 1981, 2 : 71 - 75
  • [9] Synthesis and biological properties of new constrained CCK-B antagonists: Discrimination of two affinity states of the CCK-B receptor on transfected CHO cells
    Bellier, B
    McCortTranchepain, I
    Ducos, B
    Danascimento, S
    Meudal, H
    Noble, F
    Garbay, C
    Roques, BP
    [J]. JOURNAL OF MEDICINAL CHEMISTRY, 1997, 40 (24) : 3947 - 3956
  • [10] Biro E, 1997, NEUROPEPTIDES, V31, P281